erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
cuomo's plan requires the health department to post tick collection and testing results to health data ny and make the data available to the public, which was not released before.
.
.
.